United States Oncology Market Outlook to 2025

GlobalData’s “United States Oncology Market Outlook to 2025” is a comprehensive databook report, covering key market data on the United States Oncology market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – ALK Tests, BRCA Tests, Colorectal Cancer Screening Tests, EGFR Tests, HER2 Amplification Tests and KRAS Tests.

The United States Oncology Market report provides key information and data on:

• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2015 to 2025.

• 2018 company share and distribution share data for Oncology Market.

• Global corporate-level profiles of key companies operating within the United States Oncology Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

United States Oncology Tests is segmented as follows:

• ALK Tests

• BRCA Tests

• Colorectal Cancer Screening Tests

• EGFR Tests

• HER2 Amplification Tests

• KRAS Tests

Reasons to buy

Key Reasons to Purchase – The United States Oncology Market report helps you to develop:

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

• Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Companies mentioned

Key companies covered in the “United States Oncology Market Outlook to 2025” report:

• Exact Sciences Corp

• Abbott Laboratories

• F. Hoffmann-La Roche Ltd

Table of Contents

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 4

2 Introduction 6

2.1 What Is This Report About? 6

2.2 Oncology Market Segmentation 6

2.3 Definitions of Markets Covered in the Report 7

3 Oncology Market, United States 12

3.1 Oncology Market, United States, Revenue ($m), 2015-2025 12

3.1.1 ALK Tests Market, United States, Revenue ($m), by Segment, 2015-2025 15

3.1.2 BRCA Tests Market, United States, Revenue ($m), by Segment, 2015-2025 17

3.1.3 Colorectal Cancer Screening Tests Market, United States, Revenue ($m), by Segment, 2015-2025 19

3.1.4 EGFR Tests Market, United States, Revenue ($m), by Segment, 2015-2025 22

3.1.5 HER2 Amplification Tests Market, United States, Revenue ($m), by Segment, 2015-2025 25

3.1.6 KRAS Tests Market, United States, Revenue ($m), by Segment, 2015-2025 27

3.2 Oncology Market, United States, Volume (Units), 2015-2025 29

3.2.1 ALK Tests Market, United States, Volume (Units), by Segment, 2015-2025 32

3.2.2 BRCA Tests Market, United States, Volume (Units), by Segment, 2015-2025 34

3.2.3 Colorectal Cancer Screening Tests Market, United States, Volume (Units), by Segment, 2015-2025 36

3.2.4 EGFR Tests Market, United States, Volume (Units), by Segment, 2015-2025 39

3.2.5 HER2 Amplification Tests Market, United States, Volume (Units), by Segment, 2015-2025 42

3.2.6 KRAS Tests Market, United States, Volume (Units), by Segment, 2015-2025 44

3.3 Oncology Market, United States, Average Price ($), 2015-2025 46

3.4 Oncology Market, United States, Distribution Share by Revenue ($m), 2018 50

3.5 Oncology Market, United States, Company Share by Revenue ($m), 2018 51

4 Overview of Key Companies in United States, Oncology Market 53

4.1 Exact Sciences Corp 53

4.1.1 Company Overview 53

4.2 Abbott Laboratories 53

4.2.1 Company Overview 53

4.3 F. Hoffmann-La Roche Ltd 53

4.3.1 Company Overview 53

4.4 Qiagen NV 53

4.4.1 Company Overview 53

4.5 Thermo Fisher Scientific Inc 54

4.5.1 Company Overview 54

4.6 Agilent Technologies Inc 54

4.6.1 Company Overview 54

4.7 Danaher Corp 54

4.7.1 Company Overview 54

5 Financial Deals Landscape 55

5.1 Merger 55

5.1.1 Navaux Merges with Stage I Diagnostics 55

5.2 Partnerships 56

5.2.1 Lexent Bio Enters into Partnership Agreement with Illumina 56

5.2.2 Natera and Foundation Medicine Enter into Partnership 57

5.2.3 Progenics Pharma Enters into Research Collaboration Agreement with VA Greater Los Angeles Healthcare System 59

5.2.4 Breath Diagnostics and Mayo Clinic Laboratories Enter into Collaboration 60

5.3 Private Equity 61

5.3.1 Seacoast Capital Invests USD30 Million in SkinCure Oncology 61

5.4 Venture Financing 62

5.4.1 GenomOncology Raises USD1.4 Million in Venture Financing 62

5.4.2 Apostle Raises USD3.3 Million in Series A Financing 63

6 Recent Developments 64

6.1 Other Significant Developments 64

6.1.1 Oct 18, 2019: Ochsner Health System to pilot genetic screening program in partnership with Color 64

6.1.2 Sep 09, 2019: Liquid biopsies reveal genetic alterations linked to cancer drug resistance 65

6.1.3 May 23, 2019: New approach captures detailed mid-infrared images for medical diagnostics 66

6.2 Product News 67

6.2.1 Jul 25, 2019: AI tool identifies cancer outcomes using radiology reports 67

6.2.2 Jul 19, 2019: Infrared chemical imaging technology promises new precision cancer diagnosis 68

6.2.3 Jun 06, 2019: Caris Life Sciences' Precision Oncology Alliance publishes new review of molecular testing in cancer 68

6.3 Research And Development 69

6.3.1 Oct 21, 2019: UK-US alliance launched to boost early cancer detection rates 69

6.4 Strategy And Business Planning 70

6.4.1 Oct 09, 2019: Qiagen and Illumina sign 15-year deal for IVD tests 70

6.4.2 Sep 16, 2019: Varian to invest in Oncora to develop radiation oncology tools 70

6.4.3 Aug 01, 2019: Inspirata and Fujifilm strike commercial partnership to supply digital pathology services to the UK National Health Service 71

7 Appendix 72

7.1 Research Methodology 73

7.1.1 Coverage 73

7.1.2 Secondary Research 73

7.1.3 Primary Research 74

7.1.4 Market Modeling and Forecasting 75

7.1.5 Company Share Analysis 76

7.1.6 Distribution Share Analysis 77

7.1.7 Benchmarking 77

7.2 GlobalData Consulting 77

7.3 Contact Us 78

7.4 Disclaimer 78

List of Tables

1.1 List of Tables

Table 1: Oncology Market, United States, Revenue ($m), USD Constant, 2015-2020 13

Table 2: Oncology Market, United States, Revenue ($m), USD Constant, 2021-2025 14

Table 3: ALK Tests Market, United States, Revenue ($m), USD Constant, 2015-2020 16

Table 4: ALK Tests Market, United States, Revenue ($m), USD Constant, 2021-2025 16

Table 5: BRCA Tests Market, United States, Revenue ($m), USD Constant, 2015-2020 18

Table 6: BRCA Tests Market, United States, Revenue ($m), USD Constant, 2021-2025 18

Table 7: Colorectal Cancer Screening Tests Market, United States, Revenue ($m), USD Constant, 2015-2020 20

Table 8: Colorectal Cancer Screening Tests Market, United States, Revenue ($m), USD Constant, 2021-2025 21

Table 9: EGFR Tests Market, United States, Revenue ($m), USD Constant, 2015-2020 23

Table 10: EGFR Tests Market, United States, Revenue ($m), USD Constant, 2021-2025 24

Table 11: HER2 Amplification Tests Market, United States, Revenue ($m), USD Constant, 2015-2020 26

Table 12: HER2 Amplification Tests Market, United States, Revenue ($m), USD Constant, 2021-2025 26

Table 13: KRAS Tests Market, United States, Revenue ($m), USD Constant, 2015-2020 28

Table 14: KRAS Tests Market, United States, Revenue ($m), USD Constant, 2021-2025 28

Table 15: Oncology Market, United States, Volume (Units), 2015-2020 30

Table 16: Oncology Market, United States, Volume (Units), 2021-2025 31

Table 17: ALK Tests Market, United States, Volume (Units), 2015-2020 33

Table 18: ALK Tests Market, United States, Volume (Units), 2021-2025 33

Table 19: BRCA Tests Market, United States, Volume (Units), 2015-2020 35

Table 20: BRCA Tests Market, United States, Volume (Units), 2021-2025 35

Table 21: Colorectal Cancer Screening Tests Market, United States, Volume (Units), 2015-2020 37

Table 22: Colorectal Cancer Screening Tests Market, United States, Volume (Units), 2021-2025 38

Table 23: EGFR Tests Market, United States, Volume (Units), 2015-2020 40

Table 24: EGFR Tests Market, United States, Volume (Units), 2021-2025 41

Table 25: HER2 Amplification Tests Market, United States, Volume (Units), 2015-2020 43

Table 26: HER2 Amplification Tests Market, United States, Volume (Units), 2021-2025 43

Table 27: KRAS Tests Market, United States, Volume (Units), 2015-2020 45

Table 28: KRAS Tests Market, United States, Volume (Units), 2021-2025 45

Table 29: Oncology Market, United States, Average Price ($), 2015-2020 46

Table 30: Oncology Market, United States, Average Price ($), 2021-2025 48

Table 31: Oncology Market, United States, Distribution Share by Revenue ($m), USD Constant, 2018 50

Table 32: Oncology Market, United States, Company Share by Revenue ($m), USD Constant, 2018 52

Table 33: Navaux Merges with Stage I Diagnostics 55

Table 34: Lexent Bio Enters into Partnership Agreement with Illumina 56

Table 35: Natera and Foundation Medicine Enter into Partnership 57

Table 36: Progenics Pharma Enters into Research Collaboration Agreement with VA Greater Los Angeles Healthcare System 59

Table 37: Breath Diagnostics and Mayo Clinic Laboratories Enter into Collaboration 60

Table 38: Seacoast Capital Invests USD30 Million in SkinCure Oncology 61

Table 39: GenomOncology Raises USD1.4 Million in Venture Financing 62

Table 40: Apostle Raises USD3.3 Million in Series A Financing 63

Table 41: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country 75

List of Figures

1.2 List of Figures

Figure 1: Oncology Market, United States, Revenue ($m), USD Constant, 2015-2025 12

Figure 2: ALK Tests Market, United States, Revenue ($m), USD Constant, 2015-2025 15

Figure 3: BRCA Tests Market, United States, Revenue ($m), USD Constant, 2015-2025 17

Figure 4: Colorectal Cancer Screening Tests Market, United States, Revenue ($m), USD Constant, 2015-2025 19

Figure 5: EGFR Tests Market, United States, Revenue ($m), USD Constant, 2015-2025 22

Figure 6: HER2 Amplification Tests Market, United States, Revenue ($m), USD Constant, 2015-2025 25

Figure 7: KRAS Tests Market, United States, Revenue ($m), USD Constant, 2015-2025 27

Figure 8: Oncology Market, United States, Volume (Units), 2015-2025 29

Figure 9: ALK Tests Market, United States, Volume (Units), 2015-2025 32

Figure 10: BRCA Tests Market, United States, Volume (Units), 2015-2025 34

Figure 11: Colorectal Cancer Screening Tests Market, United States, Volume (Units), 2015-2025 36

Figure 12: EGFR Tests Market, United States, Volume (Units), 2015-2025 39

Figure 13: HER2 Amplification Tests Market, United States, Volume (Units), 2015-2025 42

Figure 14: KRAS Tests Market, United States, Volume (Units), 2015-2025 44

Figure 15: Oncology Market, United States, Company Share (%) 2018 51

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 (0) 161 359 5813

Join our mailing list

Saved reports